Sessione Clinica Evidence-based Clinical Problem Solving1. Gastroenterologia
Copyright - GIMBE
• Il signor Saverio è un agente di polizia tributaria di 28 anni, fumatore, con una lunga storia di malattia di Crohn.
Copyright - GIMBE
4-87 comparsa di fistola perianale; alvo regolare
curettage chirurgico di fistola perianale
4-93 1° episodio di subocclusione intestinale
8-93 2° episodio di subocclusione intestinale
La colonscopia evidenzia una flogosi a livello ileo-colico. L'esame istologico conferma la diagnosi endoscopica di malattia di Crohn
Copyright - GIMBE
93-97 Periodiche riaccensioni della malattia con caratteristiche
prevalentemente infiammatorie trattate con steroidi o mesalazina
11-97 riacutizzazione della malattia di base a cui segue
l’ileo con anastomosi latero-laterale di ansa ileale al tratto di passaggio tra cieco ed ascendente, sul profilo interno. Le anse digiunali e la porzione residua dell’ileo appaiono normodistribuite, con pareti soffici e normale rilievovalvolare. Buona opacizzazione dell’ansa anastomotica.
Copyright - GIMBE
Stenosi tubulariforme dell’estremo distale del sigma (diametro max 1,5 cm) e dell’ampolla rettale di 10 cm. Assenza di formazioni ascessuali. Conclusioni: riacutizzazioni cliniche della malattia di base su stenosi serrata del giunto retto-sigmoideo
Copyright - GIMBE CLINICAL QUESTIONS
Copyright - GIMBE
• Quali, tra le seguenti opzioni farmacologiche, sono efficaci nella malattia di Crohn sia per indurre la remissione, che per mantenerla?
- Steroidi- Mesalazina- Immunosoppressori- Anticorpi monoclonali
• La chirurgia può essere risolutiva ?
Copyright - GIMBE
Copyright - GIMBE
Copyright - GIMBE Sandborn W, Sutherland L, Pearson D, The Cochrane Library, Issue 3, 2000. Oxford: Update Software.
Copyright - GIMBE Pearson DC, May GR, Fick G, Sutherland LR.The Cochrane Library, Issue 3, 2000. Oxford: Update Software.
Copyright - GIMBE Steinhart AH, Ewe K, Griffiths AM, The Cochrane Library, Issue 3, 2000. Oxford: Update Software.
Copyright - GIMBE
Cochrane Inflammatory Bowel Disease Group
• 5-aminosalicylate for maintaining remission of Crohn's disease• Antibiotics for inducing remission of Crohn's disease • Budesonide for inducing remission of Crohn's disease • Budesonide for maintaining remission of Crohn's disease• Cyclosporine for inducing remission of Crohn's disease• Cyclosporine for maintaining remission of Crohn's disease• Enteral nutritional therapy for inducing remission of Crohn's disease
Copyright - GIMBE Camma C, Giunta M, Rosselli M, Cottone M.
Mesalamine in the maintenance treatment of
Crohn's disease: a meta-analysis adjusted for
Gastroenterology 1997;113:1465-73.
Copyright - GIMBE
• Mesalamine may be recommended for maintaining remission of quiescent Crohn's disease.
• The benefit is mainly observed in the postsurgical setting, in patients with ileitis and with prolonged disease duration.
Camma C, et al. Gastroenterology 1997
Copyright - GIMBE
Antibodies to tumour necrosis factor alpha
Lancet. 2000 Mar 11;355(9207):858-60.
Copyright - GIMBE
Copyright - GIMBE
The role of liquid diet in the management
Copyright - GIMBE
Copyright - GIMBE
• Smoking significantly increases the risk of recurrenceof disease after operation for Crohn's disease, especially in women and heavy smokers.
• Encouraging patients to stop smoking is an important part of the management of Crohn's disease.
Copyright - GIMBE Lochs H, Mayer M, Fleig WE, et al.
Prophylaxis of postoperative relapse in Crohn's
European Cooperative Crohn's Disease Study VI. Gastroenterology 2000 Feb;118(2):264-73
Copyright - GIMBE Ewe K, Bottger T, Buhr HJ, Ecker KW, Otto HF
Low-dose budesonide treatment for prevention of
postoperative recurrence of Crohn's disease
A multicentre randomized placebo-controlled trial.
Eur J Gastroenterol Hepatol 1999 Mar;11(3):277-82
Copyright - GIMBE Hellers G, Cortot A, Jewell D, et al.
Oral budesonide for prevention of postsurgical
Gastroenterology 1999 Feb;116(2):294-300
Copyright - GIMBE
ANTI-INFLAMMEX The Ultimate Anti-Inflammatory - It Puts the Fire Out!Curcumin, the active component of TurmericBoswellia ( Boswellin serrata ) contains( Curcuma longa ), is well known for its anti-inflammatoryanti-inflammatory phytochemicals.7 The anti-properties. Several clinical trials have found Curcumin toinflammatory action of boswellic acid hasbeen demonstrated in clinical stu
01309779_Talcid 19.02.2004 13:35 Uhr Seite 1 Bitte lesen Sie folgende Gebrauchsinformation aufmerksam, weil sie wichtige Informationen darüber enthält,was Sie bei der Anwendung dieses Arzneimittels beachten sollen. Wenden Sie sich bei Fragen bitte an IhrenArzt oder Apotheker. Gebrauchsinformation Wirkstoff: Hydrotalcit, 500 mg Zusammensetzung Vorsichtsmaßnahmen für die Anwendung un